红细胞分布宽度作为预测可西布诱导的上胃肠道出血的指标
1Xincang Town Central Health Center, Pinghu City, Zhejiang Province, China.
Pakistan journal of pharmaceutical sciences
|January 17, 2026
概括
红细胞分布宽度 (RDW) 可以预测塞莱科克西布使用者的上部胃肠道出血 (UGIB). 较高的RDW水平表明风险增加,提供了具有成本效益的早期检测方法.
科学领域:
- 胃肠病学 胃肠病学
- 血液学 血液学 血液学
- 药理学 药理学是指药理学的学科.
背景情况:
- 上部胃肠道出血 (UGIB) 是使用赛莱科克西布的一个严重并发症.
- 预测性标志物用于早期识别患有塞莱科西布相关UGIB风险的患者是稀缺的.
- 红细胞分布宽度 (RDW) 是从完整血清参数中确定的一个潜在预测指标.
研究的目的:
- 评估RDW对赛莱可西布相关的UGIB的预测能力.
- 为了研究RDW与其他血液学参数之间的关系,在使用赛莱科西布的患者中.
主要方法:
- 对400名接受过塞莱科克西布的患者进行了回顾性分析.
- 将患者分为非UGIB (n=379) 和UGIB (n=21) 组.
- 分析RDW,血红蛋白 (Hb),红细胞计数 (RBC) 和血红素 (HCT) 的差异和相关性,并分析ROC曲线以获得预测价值.
主要成果:
- 与非UGIB患者相比,UGIB患者的RDW显著更高,Hb,RBC和HCT更低 (P <0.05).
- RDW与Hb (r = -0.543),RBC (r = -0.525) 和HCT (r = -0.509) 显示出显著的负相关性.
- 在16.32%的值下,RDW对UGIB预测表现出高灵敏度 (83.92%),AUC为0.773.3%.
结论:
- RDW是一种具有成本效益的生物标志物,可用于前性识别患有二次使用赛莱科克西布导致UGIB风险较高的患者.
- 需要进一步的前性试验来证实这些发现并确定临床效用.
相关概念视频
Factors Influencing Drug Absorption: Disease States and Pharmacology
1.3K
Multiple disease states can significantly influence the oral drug absorption process by affecting blood flow and the functionality of the gastrointestinal (GI) system. Various GI diseases, including conditions that alter GI motility, such as diarrhea, decreased acid secretions (achlorhydria), and infections, have been associated with reduced drug absorption.
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
1.3K
Inflammatory Bowel Disease I: Ulcerative Colitis
903
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
903
Esophageal Varices-II: Clinical Features and Management
376
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
376
Peptic Ulcer Disease I: Introduction
745
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
745
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
1.4K
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
1.4K
Esophageal Varices-I: Introduction
1.2K
Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
1.2K


